Alopecia Areata
📧 Sign up to get email alerts when something new happens for Alopecia Areata.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata [Phase 3]
This document reports an ongoing Phase 3 clinical trial of baricitinib (LY3009104) in children aged 6 to under 18 with alopecia areata, whic…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata [Phase 3]
A Phase 3 clinical trial is evaluating the safety and effectiveness of Upadacitinib tablets in adults and adolescents with severe alopecia a…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) [Phase 2]
A Phase 2 clinical trial evaluating LY4005130 in adults with severe alopecia areata is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata [Phase 2]
This entry describes a Phase 2 trial to evaluate the safety and efficacy of oral NXC-736 in adults with moderate to severe alopecia areata; …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA) [Phase 2]
A Phase 2b clinical trial (Rezolve AA) is evaluating Rezpegaldesleukin (Rezpeg) for treating severe to very severe alopecia areata in adult …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata [Phase 3]
Pfizer is conducting a Phase 3 trial of ritlecitinib in children aged 6 to 12 with severe alopecia areata, and the study is currently recrui…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata
A clinical trial is investigating whether serum VEGF-A and VCAM-1 levels associate with nailfold capillary alterations in patients with Alop…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
This document summarizes an ongoing longitudinal observational study of patients undergoing therapy for IMISC (NCT03661866) across several i…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Topical Methotrexate vs Minoxidil for Localized Alopecia Areata [Phase 4]
Phase 4 trial comparing topical methotrexate to minoxidil for localized alopecia areata; currently not recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata [Phase 4]
This update describes a Phase 4 clinical trial comparing topical calcipotriol to intralesional steroids for alopecia areata. The study statu…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata [Phase 1, Phase 2]
This clinical trial update notes that ALD-102 Solution is being studied in Phase 1/2 to evaluate safety, tolerability, pharmacokinetics, and…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Litfulo Capsules Special Investigation
Pfizer reports that a special investigation trial of Litfulo capsules in Alopecia Areata is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Dupilumab in the Treatment of Pediatric Alopecia Areata [Phase 2]
A Phase 2 clinical trial evaluating dupilumab for pediatric alopecia areata is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Pfizer is reporting a clinical trial update on ritlecitinib for Alopecia Areata, describing the characterization and clinical outcomes obser…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
A real-world, global study to assess disease burden in adolescents and adults with alopecia areata, vitiligo, or hidradenitis suppurativa.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US
Pfizer-sponsored real-world study evaluating the use and effectiveness of ritlecitinib for severe alopecia areata in the United States; recr…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA) [Phase 4]
A Phase 4 clinical trial comparing tofacitinib versus methotrexate for severe alopecia areata is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Clinical trial registry entry for CorEvitas' International Adolescent Alopecia Areata Drug Safety and Effectiveness Registry, currently recr…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
A ClinicalTrials.gov listing shows the CorEvitas Alopecia Areata Safety and Effectiveness Registry is currently recruiting to assess safety …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: PALLAS Laser for Skin Diseases [NA]
A clinical trial update indicating recruitment for a study evaluating the PALLAS Laser for skin diseases, including vitiligo, psoriasis, alo…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome [Phase 2]
A Phase 2 clinical trial is evaluating abrocitinib for atopic dermatitis and alopecia areata in individuals with Down syndrome and is curren…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study [Phase 4]
A Phase 4 pediatric trial evaluating the effectiveness of cyclosporine or methotrexate for alopecia areata, currently recruiting in routine …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata [Phase 3]
Sun Pharmaceutical's study is a Phase 3 trial evaluating the efficacy and safety of deuruxolitinib in adolescents with severe alopecia areat…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata [NA]
A clinical trial from Zagazig University is evaluating microneedling combined with either 1% lactic acid, vitamin D3 (cholecalciferol), or t…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
The LANDSCAPE study, sponsored by Fondazione ISIDE, investigates demographics and treatment patterns of patients with immune-mediated inflam…